Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuationon July 9, 2022 at 6:58 pm
Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian…